Amogastrin for the 99mTc-pertechnetate imaging of the gastric mucosa

  • Radioisotopes. 1982 Mar;31(3):141-4. doi: 10.3769/radioisotopes.31.3_141.
S Okuyama ,  H Mishina
PMID: 6285422 DOI: 10.3769/radioisotopes.31.3_141
Abstract

Most of the gastric diseases seat in the mucosa, and the present investigation was undertaken in order to see if amogastrin, a synthetic tetrapeptide, was capable of enhancing gastric accretion of intravenous 99mTc pertechnetate in man as well as in the rabbit. Improvement of gastric scintigraphy was achievable with a pretreatment of the agent by increasing the gastric accretion and reducing the background radioactivity in the liver and small intestinum.

Products